Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
15,057 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,009 Million
Pharmaceuticals & Biotechnology
ILS 100,245 Million ()
8.00
NA
0.00%
2.01
33.89%
4.19






